CRP and head and neck squamous cell carcinoma: In this study, we showed the prognostic significance of elevated on-treatment CRP levels and CRP kinetics for objective response and survival in R/M HNSCC patients receiving first-line pembrolizumab with or without concurrent chemotherapy.